ARYL (SULFIDE, SULFOXIDE AND SULFONE) DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
申请人:ONO PHARMACEUTICAL CO., LTD.
公开号:EP0994104A1
公开(公告)日:2000-04-19
Pharmaceutical composition containing aryl (sulfide, sulfoxide, sulfone) derivatives of the formula (I) and the salts thereof as active ingredient (wherein R1 is H, alkyl ; R2 is COOR7, CONHOR8 ; E is -CONR9-, -NR9CO-, -OCO-, -COO-, -CH2-O-, -(CH2)2-, vinylene, ethynylene ; J is bond, alkylene ; A is H, alkyl, Ar, alkyl-OH ; R3, R4 is H, alkyl, COOR19, hydroxy, -NR20R21,
Ar1 etc.) ; R5, R6 is H, methyl) and the novel aryl (sulfide, sulfoxide, sulfone) derivatives of the formula (I).
The compounds of the formula (I) have inhibitory activity against matrix metalloproteinases, therefore, the compounds of the formula (I) are useful for prevention and / or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstital nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury, autoimmune diseases, diseases caused by vascular emigration or infiltration of leukocytes, arterialization etc.
含有式(I)芳基(硫化物、亚砜、砜)衍生物及其盐作为活性成分的药物组合物(其中 R1 是 H、烷基;R2 是 COOR7、CONHOR8 ;E是-CONR9-、-NR9CO-、-OCO-、-COO-、-CH2-O-、-(CH2)2-、乙烯基、乙炔基;J是键、亚烷基;A是H、烷基、Ar、烷基-OH;R3、R4是H、烷基、COOR19、羟基、-NR20R21、
Ar1等);R5、R6是H、甲基)和式(I)的新型芳基(硫醚、亚砜、砜)衍生物。
式(I)化合物对基质金属蛋白酶具有抑制活性,因此,式(I)化合物可用于预防和/或治疗类风湿病、关节骨膜炎、异常骨吸收、骨质疏松症、牙周炎、间质性肾炎、动脉硬化、肺气肿、肝硬化、角膜损伤、自身免疫性疾病、白细胞血管外移或浸润引起的疾病、动脉化等。